Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Capital Reinvestment Ratio

Latest as of September 2024: 0.05x

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares capital reinvestment ratio. Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has a Capital Reinvestment Ratio of 0.05x as of September 2024, meaning it reinvests 0% of its operating cash flow ($753.12K) in capital expenditures ($41.04K). Check Hong Kong Pharma Digital Technology Hold cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$753.12K
USD

Capital Expenditures

$41.04K
USD

Data as of

Sep 2024
Most recent filing

Capital Reinvestment Ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2025)

Capital reinvestment ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2025. This chart tracks Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's Capital Reinvestment Ratio across 2 annual periods. Also explore HKPD year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Capital Reinvestment Ratio by Year (2023–2025)

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares capital reinvestment ratio by year from 2023 to 2025. For the full cash flow conversion analysis, see how efficiently does Hong Kong Pharma Digital Technology Hold generate cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.27x $569.21K $154.99K ▲ +299.5%
2023 0.07x $1.73 Million $117.70K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow